论文部分内容阅读
目的:讨论阿托伐他汀治疗冠状动脉性心脏病的效果以及相关性分析。方法:将我院2008年6月-2010年5月收治的53例冠状动脉性心脏病患者按照随机、对照原则分为两组,其中观察组27例采用阿托伐他汀治疗,对照组26例采取常规的治疗措施。观察两组症状的改变以及治疗效果。结果:观察组采用阿托伐他汀治疗后,其中17例显效,7例有效,3例治疗无效;对照组治疗后,6例显效,8例有效,12例治疗无效。观察组的治疗效果明显优于对照组,有显著性差异(P<0.05)。结论:冠状动脉性心脏病患者在临床治疗时,采用阿托伐他汀治疗,其症状的好转较为明显,可较大程度避免急性冠状动脉综合征的发生,在临床治疗中值得推广。
Objective: To discuss the effect of atorvastatin on coronary heart disease and the correlation analysis. Methods: Fifty-three patients with coronary heart disease admitted in our hospital from June 2008 to May 2010 were divided into two groups according to the randomized and controlled principle. Among them, 27 cases in the observation group were treated with atorvastatin and 26 cases in the control group Take routine treatment. Observed two groups of symptoms and treatment effects. Results: After treatment with atorvastatin in observation group, 17 cases were markedly effective, 7 cases were effective and 3 cases were ineffective. In the control group, 6 cases were markedly effective, 8 cases were effective and 12 cases were ineffective. The therapeutic effect of the observation group was significantly better than that of the control group, with significant difference (P <0.05). Conclusion: Patients with coronary heart disease are treated with atorvastatin in clinical treatment. The improvement of their symptoms is obvious, which can avoid the occurrence of acute coronary syndrome to a large extent and is worthy of promotion in clinical treatment.